Pediatric Pharmacology And Therapeutics
Expert-defined terms from the Executive Development Programme in Pediatric Research And Development course at LearnUNI. Free to read, free to share, paired with a professional course.
Acetaminophen – related terms #
paracetamol, analgesic, antipyretic. A widely used analgesic and antipyretic in children. It reduces fever by inhibiting prostaglandin synthesis in the hypothalamus. Example: 15 mg/kg every 6 hours for a 10‑kg child with fever. Practical application: first‑line for mild to moderate pain and fever. Challenges: risk of hepatotoxicity at doses >90 mg/kg/day; dosing errors due to liquid formulation concentration variations.
ACE Inhibitors – related terms #
angiotensin‑converting enzyme inhibitors, renin‑angiotensin system. Medications that block conversion of angiotensin I to angiotensin II, lowering blood pressure. Example: enalapril 0.1 mg/kg daily for pediatric hypertension. Practical application: management of chronic kidney disease and heart failure in children. Challenges: monitoring for hyperkalemia, renal function decline, and cough; limited pediatric dosing data for some agents.
Adverse Drug Reaction (ADR) – related terms #
toxicity, side effect, pharmacovigilance. Any unintended, harmful response to a medication at normal doses. Example: rash after amoxicillin administration. Practical application: systematic reporting via pediatric pharmacovigilance programs. Challenges: distinguishing ADRs from disease symptoms, under‑reporting, and age‑specific manifestation.
Allometric Scaling – related terms #
dose extrapolation, body surface area, weight‑based dosing. Method to predict pediatric drug doses based on physiological parameters such as weight or surface area. Example: converting an adult dose of 500 mg to a child using a 0.75 kg^0.75 factor. Practical application: initial dose selection for investigational drugs. Challenges: variability in metabolism among neonates, infants, and older children; limited accuracy for drugs with non‑linear kinetics.
Aminoglycosides – related terms #
gentamicin, tobramycin, nephrotoxicity. A class of antibiotics that inhibit bacterial protein synthesis. Example: gentamicin 5 mg/kg IV once daily for neonatal sepsis. Practical application: treatment of serious gram‑negative infections. Challenges: narrow therapeutic index, need for therapeutic drug monitoring, risk of ototoxicity especially in preterm infants.
Anticholinergic Burden – related terms #
dry mouth, constipation, cognitive effects. Cumulative effect of multiple anticholinergic drugs leading to adverse outcomes. Example: combination of diphenhydramine and atropine in a child with allergic reaction. Practical application: reviewing medication lists to minimize cumulative anticholinergic load. Challenges: limited pediatric reference ranges for anticholinergic activity, increased sensitivity in the developing brain.
Antibiotic Stewardship – related terms #
resistance, de‑escalation, narrow‑spectrum. Coordinated effort to optimize antibiotic use and reduce resistance. Example: switching from broad‑spectrum ceftriaxone to amoxicillin after culture results. Practical application: hospital‑wide protocols for empiric therapy in pediatric pneumonia. Challenges: balancing timely treatment of severe infections with avoidance of unnecessary broad‑spectrum exposure.
Anticonvulsants – related terms #
phenobarbital, levetiracetam, therapeutic drug monitoring. Medications used to prevent or control seizures. Example: phenobarbital loading dose 20 mg/kg followed by maintenance 3 mg/kg/day. Practical application: status epilepticus management in the emergency department. Challenges: age‑dependent pharmacokinetics, drug‑drug interactions, cognitive side effects.
Antifungal Agents – related terms #
fluconazole, amphotericin B, invasive candidiasis. Drugs that treat fungal infections. Example: fluconazole 12 mg/kg loading dose then 6 mg/kg/day for candidemia. Practical application: prophylaxis in neutropenic oncology patients. Challenges: renal toxicity with amphotericin B, limited pediatric formulations, drug interactions with azoles.
Antihistamines – related terms #
cetirizine, diphenhydramine, H1‑receptor blockade. Medications that block histamine receptors to relieve allergic symptoms. Example: cetirizine 0.25 mg/kg once daily for allergic rhinitis. Practical application: symptomatic relief of urticaria in children. Challenges: sedation with first‑generation agents, off‑label use for pruritus in atopic dermatitis.
Antimicrobial Susceptibility Testing – related terms #
MIC, CLSI guidelines, breakpoint. Laboratory method to determine the lowest drug concentration that inhibits bacterial growth. Example: MIC of 0.5 µg/mL for cefotaxime against E. coli. Practical application: guiding targeted therapy after culture results. Challenges: limited pediatric breakpoints for newer agents, turnaround time affecting early empiric decisions.
Antineoplastic Drugs – related terms #
chemotherapy, cytotoxic agents, dose intensity. Medications used to treat cancers by killing rapidly dividing cells. Example: vincristine 1.5 mg/m² weekly for childhood ALL. Practical application: curative protocols for leukemia. Challenges: severe toxicities (neurotoxicity, myelosuppression), need for precise dosing based on body surface area, long‑term sequelae.
Antipyretics – related terms #
fever reducers, ibuprofen, dosing intervals. Agents that lower elevated body temperature. Example: ibuprofen 10 mg/kg every 6–8 hours for a febrile toddler. Practical application: comfort management in viral infections. Challenges: renal safety in dehydration, dosing errors with liquid preparations.
APPROVAL Pathways – related terms #
FDA, EMA, pediatric investigation plan (PIP). Regulatory routes for bringing pediatric medicines to market. Example: obtaining a PIP waiver for a drug with existing pediatric data. Practical application: planning clinical trials that satisfy regulatory requirements. Challenges: aligning international guidelines, meeting ethical standards for pediatric participants.
Artemisinin‑Based Combination Therapies (ACTs) – related terms #
malaria treatment, resistance, lumefantrine. First‑line therapy for uncomplicated Plasmodium falciparum malaria. Example: artemether‑lumefantrine dosing 5 mg/kg artemether twice daily for 3 days. Practical application: treatment of pediatric malaria in endemic regions. Challenges: emerging resistance, ensuring adherence to multi‑day regimen.
Asthma Controllers – related terms #
inhaled corticosteroids, leukotriene modifiers, step therapy. Long‑term medications that reduce airway inflammation. Example: budesonide 0.5 µg/puff, 2 puffs twice daily via spacer. Practical application: maintenance therapy for persistent asthma. Challenges: technique errors with inhalers, growth concerns with high‑dose steroids.
Atropine – related terms #
muscarinic antagonist, bradycardia, pre‑medication. Medication that blocks vagal influence on the heart. Example: atropine 0.02 mg/kg IV for symptomatic bradycardia in a newborn. Practical application: peri‑operative management of pediatric patients. Challenges: limited dosing data for neonates, potential for central anticholinergic effects.
Beta‑Blockers – related terms #
propranolol, atenolol, heart rate control. Drugs that antagonize β‑adrenergic receptors, reducing heart rate and contractility. Example: propranolol 1 mg/kg divided TID for infantile hemangioma. Practical application: treatment of proliferative vascular tumors in infants. Challenges: monitoring for hypoglycemia, bronchospasm in asthmatic children.
Biologic Therapies – related terms #
monoclonal antibodies, cytokine inhibitors, immunomodulation. Targeted agents that modify immune pathways. Example: adalimumab 20 mg subcutaneously every other week for juvenile idiopathic arthritis. Practical application: disease‑modifying treatment for refractory autoimmune disorders. Challenges: high cost, risk of infections, limited pediatric dosing studies.
Bioavailability – related terms #
first‑pass metabolism, absorption, F‑ratio. Fraction of an administered dose that reaches systemic circulation unchanged. Example: oral ciprofloxacin bioavailability ≈ 70 % in children. Practical application: deciding route of administration for antibiotics. Challenges: variability due to gastric pH, food effects, age‑related enzymatic activity.
Blood‑Brain Barrier (BBB) – related terms #
central nervous system penetration, efflux transporters, neuropharmacology. Protective barrier that restricts drug entry into the brain. Example: limited penetration of many β‑lactams into cerebrospinal fluid. Practical application: selecting agents for pediatric meningitis. Challenges: developmental differences in BBB permeability, need for higher doses or intrathecal administration.
Bronchodilators – related terms #
albuterol, short‑acting β2‑agonist, rescue therapy. Medications that relax airway smooth muscle. Example: albuterol 0.15 mg/kg via nebulizer for acute asthma exacerbation. Practical application: emergency relief of bronchospasm. Challenges: tachyphylaxis with overuse, dosing accuracy in infants.
Calcium Channel Blockers – related terms #
amlodipine, verapamil, vascular resistance. Agents that inhibit calcium influx in vascular smooth muscle and myocardium. Example: amlodipine 0.2 mg/kg daily for pediatric hypertension. Practical application: alternative therapy when ACE inhibitors are contraindicated. Challenges: dose titration in neonates, monitoring for hypotension.
Capillary Leak Syndrome – related terms #
vascular permeability, cytokine storm, fluid overload. Condition where plasma proteins and fluid extravasate into interstitial space. Example: observed in severe sepsis treated with high‑dose steroids. Practical application: requires careful fluid management and albumin replacement. Challenges: early recognition, limited pediatric guidelines.
Cataractogenic Drugs – related terms #
corticosteroids, phenobarbital, ocular toxicity. Medications that increase risk of lens opacities. Example: prolonged systemic dexamethasone therapy in a child with nephrotic syndrome. Practical application: regular ophthalmologic screening for at‑risk children. Challenges: balancing therapeutic benefits with ocular risk, limited alternative agents.
Cefepime – related terms #
fourth‑generation cephalosporin, neutropenic fever, neurotoxicity. Broad‑spectrum antibiotic effective against gram‑negative organisms. Example: cefepime 50 mg/kg IV q8h for pediatric febrile neutropenia. Practical application: empiric coverage for resistant Pseudomonas infections. Challenges: dose‑related encephalopathy, especially in renal impairment.
Cephalosporins – related terms #
β‑lactam antibiotics, generation, cross‑reactivity. Class of antibiotics with a β‑lactam ring and varying spectrum. Example: ceftriaxone 50 mg/kg daily for bacterial meningitis. Practical application: first‑line for many pediatric infections. Challenges: appropriate selection based on generation, risk of Clostridioides difficile colitis.
Clinical Pharmacokinetics – related terms #
clearance, half‑life, volume of distribution. Study of drug absorption, distribution, metabolism, and excretion in patients. Example: calculating vancomycin troughs to achieve AUC/MIC > 400. Practical application: individualized dosing in critically ill children. Challenges: rapid physiological changes in neonates, limited sampling volume.
Clinical Pharmacodynamics – related terms #
dose‑response, receptor occupancy, therapeutic index. Relationship between drug concentration and its effect. Example: time‑dependent killing of β‑lactams requiring %T>MIC > 40 % for efficacy. Practical application: optimizing dosing intervals for antibiotics. Challenges: integrating PK/PD models with sparse pediatric data.
Compounding – related terms #
extemporaneous formulations, sterile preparation, pediatric dosing. Process of creating customized medication forms. Example: preparing a 0.5 mg/mL oral suspension of a tablet‑only drug for a toddler. Practical application: providing age‑appropriate dosage forms. Challenges: stability, dosing accuracy, regulatory compliance.
Contraindications – related terms #
absolute, relative, safety profile. Situations where a drug should not be used. Example: avoiding NSAIDs in children with severe renal impairment. Practical application: pre‑prescription screening. Challenges: incomplete pediatric safety data leading to uncertain risk assessments.
Corticosteroids – related terms #
glucocorticoids, anti‑inflammatory, adrenal suppression. Potent anti‑inflammatory agents used in many pediatric conditions. Example: prednisolone 1 mg/kg daily for acute asthma exacerbation. Practical application: rapid symptom control in allergic reactions. Challenges: growth retardation, immunosuppression, tapering protocols.
Creatinine Clearance (CrCl) – related terms #
renal function, Schwartz formula, dose adjustment. Estimate of glomerular filtration rate used to adjust drug dosing. Example: CrCl = (0.413 × height cm)/serum creatinine mg/dL for children. Practical application: dosing aminoglycosides and vancomycin. Challenges: inaccurate in rapidly changing renal function of neonates, reliance on serum creatinine which may lag behind true GFR.
Cytochrome P450 (CYP) Enzymes – related terms #
drug metabolism, isoenzymes, genetic polymorphism. Family of enzymes that metabolize many drugs. Example: CYP3A4 metabolizes midazolam; dosing reduced in neonates due to immature activity. Practical application: anticipating drug‑drug interactions in polypharmacy. Challenges: developmental expression differences, limited pediatric phenotype data.
De‑escalation – related terms #
antibiotic stewardship, step‑down therapy, culture‑guided. Process of narrowing or stopping antimicrobial therapy based on clinical data. Example: switching from broad‑spectrum meropenem to oral amoxicillin after susceptibility results. Practical application: reducing resistance pressure. Challenges: clinician hesitation, ensuring adequate coverage during transition.
Delayed‑Release Formulations – related terms #
enteric coating, timed release, pediatric swallowing. Dosage forms designed to release drug at a specific site or time. Example: delayed‑release omeprazole capsules for pediatric GERD. Practical application: protecting acid‑labile drugs. Challenges: crushing may destroy coating, dosing accuracy in children.
Dexamethasone – related terms #
potent glucocorticoid, anti‑emetic, cerebral edema. High‑potency steroid used for various pediatric indications. Example: dexamethasone 0.15 mg/kg IV for croup. Practical application: reducing airway inflammation in viral laryngotracheobronchitis. Challenges: hyperglycemia, behavioral changes, need for taper.
Drug‑Drug Interaction (DDI) – related terms #
pharmacokinetic interaction, synergism, antagonism. Alteration of one drug’s effect by another. Example: increased warfarin effect when combined with azithromycin. Practical application: medication reconciliation in pediatric oncology units. Challenges: limited pediatric interaction databases, polypharmacy in chronic disease.
Drug‑Food Interaction – related terms #
absorption interference, grapefruit effect, meals. Influence of food on drug pharmacokinetics. Example: decreased absorption of levothyroxine when taken with soy formula. Practical application: counseling families on timing of medication relative to meals. Challenges: variable dietary habits, lack of pediatric-specific studies.
Drug‑Induced Liver Injury (DILI) – related terms #
hepatotoxicity, ALT elevation, monitoring. Liver damage caused by medication exposure. Example: elevated transaminases after prolonged isoniazid therapy. Practical application: routine liver function testing during TB treatment. Challenges: differentiating DILI from viral hepatitis, limited pediatric thresholds.
Drug‑Induced QT Prolongation – related terms #
arrhythmia risk, torsades de pointes, ECG monitoring. Lengthening of cardiac repolarization that may precipitate dangerous arrhythmias. Example: macrolide antibiotics (e.g., azithromycin) can modestly prolong QT in susceptible children. Practical application: ECG before initiating therapy in children with congenital long QT syndrome. Challenges: lack of pediatric QTc normative data, polypharmacy compounding risk.
Drug‑Likeness – related terms #
Lipinski’s rule, oral bioavailability, pediatric formulation. Set of physicochemical properties that predict suitability for drug development. Example: a molecule with MW < 500 Da, logP < 5, ≤ 5 hydrogen bond donors is considered drug‑like. Practical application: early screening of pediatric candidates. Challenges: many pediatric drugs require non‑oral routes, deviating from classic rules.
Drug‑Monitoring Programs – related terms #
therapeutic drug monitoring, TDM, population pharmacokinetics. Systems to track drug concentrations and outcomes. Example: vancomycin troughs measured before the fourth dose. Practical application: ensuring efficacy while avoiding toxicity. Challenges: limited sampling windows in children, need for rapid assay turnaround.
Drug‑Resistance – related terms #
antimicrobial resistance, MDR, ESBL. Ability of pathogens to survive exposure to antimicrobial agents. Example: MRSA colonization in a pediatric intensive care unit. Practical application: infection control policies and targeted therapy. Challenges: rapid spread in community settings, limited new pediatric antibiotics.
Drug‑Target Interaction – related terms #
binding affinity, receptor agonist, enzyme inhibition. Molecular engagement that produces a pharmacologic effect. Example: binding of albuterol to β2‑adrenergic receptors causing bronchodilation. Practical application: rational drug design for pediatric asthma. Challenges: age‑dependent receptor expression, off‑target effects.
Drug‑Transporters – related terms #
P‑gp, OATP, efflux pumps. Proteins that move drugs across cell membranes. Example: P‑glycoprotein limits brain penetration of many chemotherapeutics. Practical application: predicting CNS drug levels in pediatric oncology. Challenges: ontogeny of transporter expression, variability among individuals.
Elimination Half‑Life – related terms #
t½, clearance, dosing interval. Time required for plasma concentration to fall by 50 %. Example: half‑life of gentamicin ≈ 2 hours in term neonates, extending to 3–4 hours in preterm infants. Practical application: determining dosing frequency. Challenges: rapid changes in half‑life during growth, impact on accumulation.
Enzyme Induction – related terms #
up‑regulation, CYP450, metabolic activation. Process where a drug increases the activity of metabolic enzymes, reducing its own or co‑administered drug levels. Example: phenobarbital induces CYP3A4, decreasing plasma levels of concomitant steroids. Practical application: dose adjustments for interacting medications. Challenges: unpredictable induction magnitude in children, delayed onset.
Enzyme Inhibition – related terms #
down‑regulation, competitive inhibition, drug interactions. Decrease in enzyme activity leading to higher drug concentrations. Example: ketoconazole inhibits CYP3A4, raising levels of certain antivirals. Practical application: avoiding toxicity in polypharmacy. Challenges: limited pediatric data on inhibition potency.
Enteral Nutrition – related terms #
tube feeding, oral supplementation, drug absorption. Delivery of nutrients via gastrointestinal tract. Example: co‑administration of antiepileptic drugs with formula may affect bioavailability. Practical application: timing medication administration 30 minutes before feeds. Challenges: variable gastric pH, interaction with high‑fat formulas.
Epinephrine – related terms #
adrenaline, anaphylaxis, vasoconstriction. First‑line treatment for severe allergic reactions. Example: 0.01 mg/kg IM for pediatric anaphylaxis. Practical application: emergency department protocols for anaphylaxis. Challenges: dosing errors, needle phobia, limited auto‑injector sizes for small children.
Erythromycin – related terms #
macrolide antibiotic, gastric motility, drug interaction. Antibiotic with pro‑kinetic properties in neonates. Example: erythromycin 10 mg/kg q6h for suspected chlamydial infection. Practical application: promoting gastric emptying in preterm infants. Challenges: risk of infantile hypertrophic pyloric stenosis, drug‑drug interactions via CYP3A4.
Excipients – related terms #
inactive ingredients, formulation, safety. Non‑active components of a drug product. Example: propylene glycol in oral syrups can cause toxicity in infants. Practical application: selecting excipient‑free formulations for neonates. Challenges: limited labeling of excipient content, hidden allergens.
Extended‑Release (ER) Formulations – related terms #
sustained release, once‑daily dosing, pediatric adherence. Dosage forms that release drug over an extended period. Example: ER methylphenidate 20 mg once daily for ADHD. Practical application: improving compliance in school‑aged children. Challenges: inability to split tablets, risk of dose dumping if crushed.
Fetal Exposure – related terms #
maternal drug therapy, teratogenicity, placental transfer. Drug presence in the developing fetus during pregnancy. Example: prenatal exposure to valproic acid associated with neural tube defects. Practical application: counseling pregnant patients on medication risks. Challenges: limited data on many newer agents, ethical constraints on studies.
First‑Pass Metabolism – related terms #
hepatic clearance, oral bioavailability, prodrugs. Metabolic process that reduces drug concentration before reaching systemic circulation. Example: oral propranolol undergoes significant first‑pass effect, requiring higher doses. Practical application: choosing non‑oral routes for drugs with high first‑pass loss. Challenges: variable hepatic enzyme activity in infants.
Fluoroquinolones – related terms #
ciprofloxacin, cartilage toxicity, broad‑spectrum. Antibiotics with activity against gram‑negative organisms. Example: ciprofloxacin 20 mg/kg q12h for pediatric cystic fibrosis exacerbation. Practical application: reserved for resistant infections. Challenges: concerns about arthropathy in growing children, limited pediatric labeling.
Formulary Management – related terms #
drug selection, cost containment, therapeutic guidelines. Process of curating approved medications within a health system. Example: inclusion of a pediatric‑specific oral suspension of amoxicillin in the hospital formulary. Practical application: ensuring availability of age‑appropriate drugs. Challenges: balancing cost with need for specialized formulations.
Furosemide – related terms #
loop diuretic, renal excretion, electrolyte loss. Medication that promotes diuresis by inhibiting sodium‑potassium‑chloride transport. Example: furosemide 1 mg/kg IV bolus for pulmonary edema in a child with congenital heart disease. Practical application: rapid fluid removal pre‑operatively. Challenges: ototoxicity at high doses, monitoring for hypokalemia.
Genetic Polymorphism – related terms #
pharmacogenomics, CYP2D6, metabolizer status. Variation in DNA sequence affecting drug metabolism. Example: poor metabolizer phenotype for CYP2D6 leading to higher concentrations of codeine‑derived morphine. Practical application: avoiding codeine in children with known polymorphisms. Challenges: limited routine testing, ethnic variability.
Glomerular Filtration Rate (GFR) – related terms #
renal clearance, creatinine clearance, dosing adjustment. Measure of kidney function. Example: GFR estimation using the bedside Schwartz equation for dosing aminoglycosides. Practical application: adjusting drug regimens in acute kidney injury. Challenges: rapid changes in neonates, influence of muscle mass on creatinine.
Growth Monitoring – related terms #
anthropometry, dosing adjustments, long‑term safety. Regular assessment of a child’s physical development. Example: recalculating chemotherapy doses based on weight gain during treatment. Practical application: ensuring appropriate exposure to therapeutic agents. Challenges: frequent dose recalculations increase workload, risk of dosing errors.
Hepatotoxicity – related terms #
liver injury, ALT elevation, drug safety. Toxic effect of a drug on liver tissue. Example: elevated transaminases after prolonged isoniazid use. Practical application: periodic liver function tests during TB therapy. Challenges: distinguishing drug‑induced injury from viral hepatitis, especially in endemic areas.
High‑Alert Medications – related terms #
risk of severe harm, insulin, anticoagulants. Drugs that require extra safety measures. Example: insulin dosing in a toddler with type 1 diabetes. Practical application: double‑check protocols and standardized dosing charts. Challenges: pediatric dosing complexity, need for caregiver education.
Hydrocortisone – related terms #
glucocorticoid, adrenal insufficiency, stress dosing. Steroid used for adrenal replacement and anti‑inflammatory purposes. Example: hydrocortisone 2 mg/kg IV bolus for adrenal crisis. Practical application: stress dosing during surgery. Challenges: accurate stress‑dose calculations, preventing over‑replacement.
Hyperthermia Management – related terms #
fever control, cooling blankets, antipyretics. Strategies to reduce dangerously high body temperature. Example: using a tepid sponge and ibuprofen for a child with temperature > 41 °C. Practical application: preventing febrile seizures. Challenges: differentiating hyperthermia from malignant hyperthermia, ensuring safe cooling methods.
Immunogenicity – related terms #
anti‑drug antibodies, biologics, loss of efficacy. Immune response against a therapeutic agent. Example: development of anti‑infliximab antibodies reducing drug efficacy in juvenile arthritis. Practical application: monitoring trough levels and switching to another biologic. Challenges: limited pediatric data on incidence, impact on dosing intervals.
Inhalation Therapy – related terms #
spacer device, nebulizer, aerosolized medication. Delivery of medication directly to the respiratory tract. Example: nebulized albuterol 0.15 mg/kg for acute bronchiolitis. Practical application: rapid relief of airway obstruction. Challenges: ensuring proper technique, coordinating breathing with device activation.
Intravenous Immunoglobulin (IVIG) – related terms #
immune therapy, Kawasaki disease, dose‑dependent. Pooled human antibodies used for immune modulation. Example: IVIG 2 g/kg over 12 hours for Kawasaki disease. Practical application: reducing coronary artery aneurysm risk. Challenges: infusion reactions, high cost, volume overload in small infants.
Intrathecal Administration – related terms #
spinal delivery, chemotherapy, CSF penetration. Direct injection into cerebrospinal fluid. Example: methotrexate 12 mg intrathecally for pediatric CNS leukemia. Practical application: achieving therapeutic CSF concentrations. Challenges: aseptic technique, risk of meningitis, dosing precision.
Ketamine – related terms #
NMDA antagonist, dissociative anesthesia, analgesia. Versatile agent used for induction and procedural pain control. Example: ketamine 1 mg/kg IV for rapid sequence induction in a trauma child. Practical application: maintaining airway reflexes while providing analgesia. Challenges: emergence reactions, dosing in infants, potential for increased intracranial pressure.
Kidney Function Monitoring – related terms #
serum creatinine, urine output, nephrotoxicity. Ongoing assessment of renal performance during drug therapy. Example: daily creatinine measurement during aminoglycoside treatment. Practical application: early detection of nephrotoxic injury. Challenges: interpreting creatinine in low‑muscle‑mass infants, delayed rise after injury.
Leukotriene Modifiers – related terms #
montelukast, asthma adjunct, anti‑inflammatory. Oral agents that block leukotriene pathways. Example: montelukast 4 mg nightly for a 12‑kg child with mild persistent asthma. Practical application: alternative or add‑on therapy for allergic rhinitis. Challenges: adherence due to daily oral dosing, limited efficacy in severe disease.
Linezolid – related terms #
oxazolidinone, MRSA, myelosuppression. Antibiotic effective against resistant gram‑positive organisms. Example: linezolid 10 mg/kg q8h IV for pediatric MRSA pneumonia. Practical application: treatment of infections where vancomycin fails. Challenges: thrombocytopenia with prolonged use, drug‑food interaction with tyramine‑rich foods.
Liquid Formulations – related terms #
oral suspension, concentration variability, dosing accuracy. Dosage forms designed for children unable to swallow tablets. Example: amoxicillin 250 mg/5 mL suspension. Practical application: flexible dosing based on weight. Challenges: ensuring correct measurement, stability over time, parental understanding.
Long‑Acting β2‑Agonists (LABA) – related terms #
salmeterol, formoterol, asthma control. Medications that provide prolonged bronchodilation. Example: salmeterol 50 µg inhaled twice daily for a 10‑year‑old with moderate asthma. Practical application: combination therapy with inhaled steroids. Challenges: risk of asthma‑related death if used without steroids, limited pediatric labeling.
Magnesium Sulfate – related terms #
seizure prophylaxis, pre‑eclampsia, neuroprotection. Electrolyte used for various neurologic and obstetric indications. Example: 50 mg/kg IV bolus for eclampsia‑related seizures in a pregnant adolescent. Practical application: neuroprotection in preterm infants with hypoxic‑ischemic encephalopathy. Challenges: monitoring serum levels, potential for hypotension.
Malabsorption Syndromes – related terms #
celiac disease, cystic fibrosis, drug absorption. Conditions that impair nutrient and drug uptake. Example: reduced oral absorption of fat‑soluble vitamins in cystic fibrosis patients. Practical application: adjusting doses of lipophilic drugs like itraconazole. Challenges: variable severity, need for individualized dosing strategies.
Metabolic Enzyme Maturation – related terms #
developmental pharmacokinetics, CYP450 ontogeny, age‑related dosing. Progressive increase in enzyme activity after birth. Example: CYP2D6 activity reaches adult levels by 2 years of age. Practical application: scaling doses of drugs metabolized by maturing enzymes. Challenges: inter‑individual variability, limited data for premature infants.
Metformin – related terms #
biguanide, insulin sensitizer, pediatric type 2 diabetes. Oral hypoglycemic agent used off‑label in adolescents. Example: metformin 500 mg twice daily for a 14‑year‑old with obesity‑related insulin resistance. Practical application: weight‑neutral glucose control. Challenges: gastrointestinal intolerance, limited pediatric safety data.
Midazolam – related terms #
benzodiazepine, sedation, rapid onset. Short‑acting sedative used in procedures. Example: midazolam 0.2 mg/kg oral for pre‑procedural anxiolysis. Practical application: facilitating imaging studies in children. Challenges: respiratory depression, variable metabolism in neonates.
Minimum Inhibitory Concentration (MIC) – related terms #
susceptibility testing, pharmacodynamics, breakpoint. Lowest concentration of an antimicrobial that inhibits visible growth. Example: MIC of 0.125 µg/mL for vancomycin against Staphylococcus aureus. Practical application: guiding antibiotic dosing to achieve target %T>MIC. Challenges: laboratory variability, interpreting pediatric breakpoints.
Monoclonal Antibodies – related terms #
biologic agents, target specificity, immunotherapy. Engineered antibodies that bind specific antigens. Example: rituximab 375 mg/m² IV for pediatric non‑Hodgkin lymphoma. Practical application: targeted depletion of B‑cells. Challenges: infusion reactions, immunosuppression, high cost.
Mucositis Management – related terms #
oral care, chemotherapy side effect, analgesia. Inflammation and ulceration of the mucous membranes. Example: benzydamine mouthwash for pain relief during chemotherapy. Practical application: maintaining nutrition and oral intake. Challenges: infection risk, limited pediatric formulations.
Neonatal Pharmacology – related terms #
preterm infants, developmental pharmacokinetics, dosing challenges. Study of drug therapy in newborns. Example: dosing of surfactant therapy for respiratory distress syndrome. Practical application: safe medication administration in NICU. Challenges: immature organ systems, limited clinical trial data.
Nephrotoxic Agents – related terms #
renal injury, contrast media, dosing adjustment. Drugs that can impair kidney function. Example: high‑dose ibuprofen causing acute tubular necrosis. Practical application: renal function monitoring when using aminoglycosides. Challenges: distinguishing drug‑induced injury from sepsis‑related AKI.
Neurodevelopmental Toxicity – related terms #
cognitive impairment, developmental delay, long‑term outcomes. Adverse effects of drugs on brain development. Example: prolonged exposure to phenobarbital associated with lower IQ scores. Practical application: minimizing duration of sedative use in ICU. Challenges: balancing seizure control with developmental risk.
Neutropenia – related terms #
low neutrophil count, infection risk, chemotherapy. Reduced neutrophil numbers increasing infection susceptibility. Example: ANC < 500 cells/µL after cyclophosphamide. Practical application: prophylactic antibiotics and growth factor support. Challenges: dose reductions may compromise cancer treatment efficacy.
Non‑Steroidal Anti‑Inflammatory Drugs (NSAIDs) – related terms #
ibuprofen, naproxen, COX inhibition. Medications that reduce inflammation and pain. Example: ibuprofen 10 mg/kg q6h for fever. Practical application: first‑line for mild pain. Challenges: renal toxicity, gastrointestinal bleeding, contraindications in dehydration.
NSAID‑Induced Gastrointestinal Toxicity – related terms #
ulceration, proton pump inhibitors, protective agents. Damage to gastric mucosa from NSAID use